President Trump’s executive orders and legislative proposals from Congress leverage FDA to help lower drug prices, address anti-competitive practices, and accelerate generic drug approvals....more
6/24/2025
/ Anti-Competitive ,
Biosimilars ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Expedited Approval Process ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Imports ,
Most-Favored Nations ,
Patents ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Trump Administration
FDA issued a draft guidance that lays the groundwork for drug companies to comply with changes to approved color additives....more
FDA enforcement activities range from administrative actions like conducting establishment inspections and issuing warning letters to judicial enforcement through the Department of Justice, which can take the shape of civil...more